Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

CB-5083, p97 AAA ATPase Inhibitor

CB-5083, p97 AAA ATPase Inhibitor

$129.00
A highly potent, selective and orally bioavailable p97 AAA ATPase inhibitor.
Catalog No. Unit Price Qty
M60306-2s 2 mg solid $129.00

Details

Product Information
Molecular Weight: 413.47
Formula: C24H23N5O2
Purity: ≥98%
CAS#: 1542705-92-9
Solubility: DMSO up to 100 mM
Chemical Name: 1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

CB-5083 is a highly potent, selective and orally bioavailable p97 AAA ATPase inhibitor with IC50 ~11 nM. Treatment of tumor cells with CB-5083 leads to accumulation of poly-ubiquitinated proteins, retention of endoplasmic reticulum-associated degradation (ERAD) substrates, and generation of irresolvable proteotoxic stress, leading to activation of the apoptotic arm of the unfolded protein response. In xenograft models, CB-5083 causes modulation of key p97-related pathways, induces apoptosis, and has antitumor activity in a broad range of both hematological and solid tumor models.

How to Use:

In vitro: CB-5083 was used at 1-2.5 µM final concentration in various assays.
In vivo: CB-5083 was dosed to mice orally at 25-100 mg/Kg once or twice per day.

Reference:

  • 1. Zhou HJ, et al. Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). (2015) J Med Chem. 58(24):9480-97. 
  • 2. Anderson DJ, et al. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis. (2015) Cancer Cell. 28(5):653-65. 



CB-5083_spec.pdf      
CB5083_MSDS.pdf      


Products are for research use only. Not for human use.

Description

Details

Product Information
Molecular Weight: 413.47
Formula: C24H23N5O2
Purity: ≥98%
CAS#: 1542705-92-9
Solubility: DMSO up to 100 mM
Chemical Name: 1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

CB-5083 is a highly potent, selective and orally bioavailable p97 AAA ATPase inhibitor with IC50 ~11 nM. Treatment of tumor cells with CB-5083 leads to accumulation of poly-ubiquitinated proteins, retention of endoplasmic reticulum-associated degradation (ERAD) substrates, and generation of irresolvable proteotoxic stress, leading to activation of the apoptotic arm of the unfolded protein response. In xenograft models, CB-5083 causes modulation of key p97-related pathways, induces apoptosis, and has antitumor activity in a broad range of both hematological and solid tumor models.

How to Use:

In vitro: CB-5083 was used at 1-2.5 µM final concentration in various assays.
In vivo: CB-5083 was dosed to mice orally at 25-100 mg/Kg once or twice per day.

Reference:

  • 1. Zhou HJ, et al. Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). (2015) J Med Chem. 58(24):9480-97. 
  • 2. Anderson DJ, et al. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis. (2015) Cancer Cell. 28(5):653-65. 



CB-5083_spec.pdf      
CB5083_MSDS.pdf      


Products are for research use only. Not for human use.

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: